Perlara utilizes model organisms (S. cerevisiae, C. elegans and D. melanogaster) in phenotypic screens to identify therapeutic candidates for rare genetic diseases. We have no openings at this time.


Startup Life from our Blog

Last month in tweets – November 2018

Hello readers! Last month, we resurrected the old Perlara tradition of recapping the previous month through tweets. It's a monthly roundup of what happened at Perlara - new partnerships, staff news, events that Perlara team members attended, and anything else that was...

read more

CFTR-pancreatitis PerlQuest update

In our previous CFTR-pancreatitis blog post, I discussed our plan of action for developing yeast models of pancreatitis-associated CFTR variants as a part of our Pancreatitis PerlQuest partnership with Mission: Cure. In this post, I will share with you the progress...

read more

Perlara logo 300x108px

Follow Us

Join our mailing list

Translate »